CAS: 329-89-5; 6-Aminopyridine-3-Carboxamide

该化合物是属于尼可丁胺衍生物类别的化学化合物,其特点是,在环的6处位置存在氨基组,这是将其与其他尼可丁胺衍生物区别开来的一个关键特征.该化合物一般是白色到白色的晶状固体,在水和各种有机溶剂中溶解,使其具有多种用途. 6-Aminonicominamid因其在生物化学研究中的作用而著称,特别是在细胞代谢学研究中,并因其参与抑制某些酶而成为潜在的治疗剂.已经调查了该化合物对各种生物途径的影响,包括氧化性压力和炎.此外,该化合物还可能表现出抗氧化剂特性,有助于其在药理学应用中的潜在用途.与许多化学物质一样,在实验室环境中与6-氨基磷化物合作时,适当的处理和安全防范措施至关重要.

结构式图片

相似化合物

4214-73-7 13438-65-8 156973-09-0

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

6-aminonicotinonitrile 6-chloro-3-pyridinecarboxamide ethyl-6-amino-nicotinate 6-acetylamino-nicotinic acid amide 6-aminonicotinic acid ethyl-6-amino-nicotinate 2-amino-5-aminomethyl-pyridine 2-phenylimidazo[1,2-a]pyridine-6-carboxamide

合成工艺路线路线简述

    2-氨基-5-氰基吡啶置于sodium Hydroxide,双氧水体系中,化学反应生成 6-氨基烟酰胺
    参考文献:I. Derivatives Of Aminopyridines1
    标题:I. Derivatives Of Aminopyridines1
    摘要:
    DOI:10.1021/ja01197A047

    海关参考信息

    专利信息


    专利号:US-5424432-A
    优先权日:1994-05-26
    标题:Process for the preparation of imidazolutidine
    发明人:FREDENBURGH LAURA E; LARSEN ROBERT D; LIU JI; REAMER ROBERT A; SENANAYAKE CHRIS H; VERHOEVEN THOMAS R
    权利人:MERCK & CO INC
    摘要:This invention relates to a method for the preparation of a compound of formula I: I a key intermediate in the synthesis of a series of Angiotensin II receptor antagonists. The invention also relates to a selective reagent for conducting the Hofmann rearrangement, particularly in the formation of a pyridinoimidazolone, which is a percursor to the formation of an imidazopyfidine of formula I. This invention also relates to a method for the preparation of imidazolutidine, a key intermediate in the synthesis of 3-(2'-(N-benzoyl)sulfonamidobiphen-4-yl)-methyl-5,7 -dimethyl-2-ethyl-3H-imidazo[4,5-b]pyridine, using pyridinoimidazolone, an unreactive urea.

    专利号:US-2023266302-A1
    优先权日:2020-07-24
    标 题:Synthesis and use of n-benzyl sulfonamides
    发明人:LAMAR ANGUS A; SHEAFF ROBERT J
    权利人:THE UNIV OF TULSA
    摘要:Disclosed is a method for preparing N-benzyl sulfonamides. Also disclosed is a composition for treating cancer. The composition includes a N-benzyl sulfonamide and a metabolic inhibitor. Also disclosed is a method for determining the impact on cell ATP levels of a composition containing a N-benzyl sulfonamide with or without a metabolic inhibitor.

    专利号:EP-1789107-B1
    优先权日:2004-08-30
    标题 :Medical stent provided with inhibitors of atp synthesis
    发明人:POPOWSKI YOURI
    权利人:INTERSTITIAL THERAPEUTICS
    摘要:The present invention relates to a stent provided with a composition comprising at least one type of inhibitor of ATP synthesis optionally together with at least one inhibitor of the pentose phosphate pathway (PPP) for use in treating stenosis and preventing restenosis in vascular ducts, and for use in treating cancerous tumours present in ducts, resectioned cavities and scars, and for use in treating any disorder arising from the proliferation of cells in ducts or cavities.

    专利号:US-6506572-B2
    优先权日:1999-02-26
    标题 :Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy
    发明人:BIEDERMANN ELFI; EISENBURGER ROLF; HASMANN MAX; LOESER ROLAND; RATTEL BENNO; REITER FRIEDEMANN; SCHEIN BARBARA; SCHEMAINDA ISABEL; SCHULZ MICHAEL; SEIBEL KLAUS; VOGT KLAUS; WOSIKOWSKI KATJA
    权利人:KLINGE CO CHEM PHARM FAB
    摘要:New biologically active compounds are described which inhibit the cellular formation of niacinamide mononucleotide, and essential intermediate of the NAD(P) biosynthesis in the cell. These compounds can represent the active ingredient of a pharmaceutical composition for the treatment of cancers, leukaemias or for immunosuppression. Furthermore, screening methods are described as a tool for detecting the above active compounds, and for examination of a given cell type for its dependency on niacinamide as a precursor for NAD synthesis.

    专利号:US-6531470-B1
    优先权日:1998-01-23
    标题:Oxazolidinone combinatorial libraries, compositions and methods of preparation
    发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V; NI ZHI-JIE; GORDON ERIC
    权利人:UPJOHN CO
    摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.

    专利号:US-6562844-B2
    优先权日:1998-01-23
    标 题:Oxazolidinone combinatorial libraries, compositions and methods of preparation
    发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V; NI ZHI-JIE; GORDON ERIC
    权利人:UPJOHN CO
    摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.
    石家庄元冲生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    电话:18033710157👤
    ⚠️参考联系方式
    邮件:508885158@qq.com
    销售经理: 李闪闪经理
    联系电话:18033710157
    手机号码: 18033710157
    传真号码: 18033710157
    QQ号:508885158
    河北省石家庄市高新区汾河道69号
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    河北省石家庄市高新区汾河道69号
    ⚠️ 未注册 · 未认证企业
    注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Almugadam Sh, Et Al. Influence Of 6-Aminonicotinamide (6An) On Leishmania Promastigotes Evaluated By Metabolomics: Beyond The Pentose Phosphate Pathway. Chem Biol Interact. 2018;294:167-177.
    [参考文献]: Cheng J, Et Al. Trim21 And Phlda3 Negatively Regulate The Crosstalk Between The Pi3K/akt Pathway And Ppp Metabolism. Nat Commun. 2020;11(1):1880. Published 2020 Apr 20.
    [参考文献]: Koutcher Ja, Et Al. Effect Of 6-Aminonicotinamide On The Pentose Phosphate Pathway: 31P Nmr And Tumor Growth Delay Studies. Magn Reson Med. 1996;36(6):887-892.
    [参考文献]: Tsouko E, Et Al. Regulation Of The Pentose Phosphate Pathway By An Androgen Receptor-Mtor-Mediated Mechanism And Its Role In Prostate Cancer Cell Growth. Oncogenesis. 2014;3(5):E103. Published 2014 May 26.
    [参考文献]: Ayan K Ghosh, Et Al. Metabolic Reconfiguration Of The Central Glucose Metabolism: A Crucial Strategy Of Leishmania Donovani For Its Survival During Oxidative Stress. Faseb J. 2015 May;29(5):2081-98.

    合成参考文献


    参考文献:10.1007/s00775-011-0817-4
    摘要:West AK, Leung JYK, Chung RS. Neuroprotection and regeneration by extracellular metallothionein via lipoprotein-receptor-related proteins. JBIC Journal of Biological Inorganic Chemistry. 2011 Jul 21;16(7):1115. doi: 10.1007/s00775-011-0817-4.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知